NTLA-2001
Intellia Therapeutics
['crispr']
will crispr-based in-vivo genome editing in humans be the next breakthrough for attr-amyloidosis? watch my interview with dr. gillmore and dr. lebwohl here #aha22 url here: 
Non-Profit Founder/Leader | ?? Doc | Artist | Scientist | Educator | News Anchor https://t.co/usmuA3tKft | RT ? endorse | Disclaimer: https://t.co/bwmE2O3U5W